Loading...
XSHE
300981
Market cap801mUSD
Oct 10, Last price  
13.37CNY
1D
0.15%
1Q
8.61%
IPO
-75.49%
Name

Zhonghong Pulin Medical Products Co Ltd

Chart & Performance

D1W1MN
No data to show
P/E
—
P/S
2.33
EPS
—
Div Yield, %
3.74%
Shrs. gr., 5y
0.31%
Rev. gr., 5y
15.98%
Revenues
2.46b
+16.69%
550,611,138585,048,800604,083,100710,080,600951,153,298967,534,1271,170,814,0404,778,406,8724,909,310,9361,572,568,5132,105,249,6072,456,650,714
Net income
-87m
L-33.42%
3,035,80724,917,20042,313,40038,214,70065,010,53556,669,36289,266,0182,663,518,7162,341,903,87966,916,009-130,870,579-87,128,895
CFO
184m
+30.73%
13,365,927133,333,00092,230,044102,368,25296,027,72223,766,227184,382,5612,719,677,0592,362,497,606106,707,621140,676,906183,912,342
Dividend
Jun 27, 20240.5 CNY/sh

Profile

Zhonghong Pulin Medical Products Co., Ltd. researches, develops, manufactures, and sells plastic gloves. Its products include disposable vinyl and nitrile gloves for use in the medical, food service, and electronic industries. The company was founded in 2010 and is based in Tangshan, China. Zhonghong Pulin Medical Products Co., Ltd. operates as a subsidiary of Zhonghong Pulin Group Co., Ltd.
URL
https://www.zhonghongmedical.com/
IPO date
Apr 27, 2021
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,456,651
16.69%
2,105,250
33.87%
1,572,569
-67.97%
Cost of revenue
2,260,731
2,174,557
1,507,022
Unusual Expense (Income)
NOPBT
195,920
(69,307)
65,546
NOPBT Margin
7.98%
4.17%
Operating Taxes
18,927
(10,003)
Tax Rate
9.66%
NOPAT
176,993
(59,304)
65,546
Net income
(87,129)
-33.42%
(130,871)
-295.57%
66,916
-97.14%
Dividends
(215,943)
(294,640)
(500,010)
Dividend yield
4.24%
4.78%
8.87%
Proceeds from repurchase of equity
(10,026)
(8,957)
BB yield
0.20%
0.15%
Debt
Debt current
391,527
153,545
57,007
Long-term debt
347,362
345,868
20,251
Deferred revenue
20,895
17,578
20,555
Other long-term liabilities
18,803
3,676
Net debt
(139,596)
(2,913,815)
(2,949,635)
Cash flow
Cash from operating activities
183,912
140,677
106,708
CAPEX
(107,402)
(103,064)
Cash from investing activities
(513,878)
205,517
(75,214)
Cash from financing activities
138,983
39,993
FCF
(646,120)
(6,286)
(590,408)
Balance
Cash
2,325,057
2,934,938
3,026,894
Long term investments
(1,446,573)
478,290
Excess cash
755,652
3,307,966
2,948,266
Stockholders' equity
3,923,828
4,105,041
4,326,736
Invested Capital
5,616,243
3,117,988
3,268,044
ROIC
4.05%
2.31%
ROCE
3.07%
1.05%
EV
Common stock shares outstanding
396,040
384,913
390,008
Price
12.86
-19.73%
16.02
10.89%
14.45
-57.71%
Market cap
5,093,080
-17.40%
6,166,314
9.45%
5,634,112
-57.71%
EV
5,100,068
3,399,434
2,697,681
EBITDA
415,460
137,236
213,411
EV/EBITDA
12.28
24.77
12.64
Interest
25,856
15,354
1,662
Interest/NOPBT
13.20%
2.54%